Total Payments
$3,562
2024 Payments
$239.84
Companies
19
Transactions
169
Medicare Patients
6,115
Medicare Billing
$436,745
Payment Breakdown by Category
Food & Beverage$3,297 (92.5%)
Education$265.44 (7.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,297 | 165 | 92.5% |
| Education | $265.44 | 4 | 7.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,206 | 66 | $0 (2024) |
| Incyte Corporation | $371.10 | 16 | $0 (2024) |
| Janssen Biotech, Inc. | $320.33 | 14 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $240.57 | 12 | $0 (2023) |
| Sun Pharmaceutical Industries Inc. | $182.65 | 6 | $0 (2023) |
| LEO Pharma Inc. | $174.69 | 8 | $0 (2023) |
| GENZYME CORPORATION | $140.25 | 2 | $0 (2023) |
| Lilly USA, LLC | $136.12 | 7 | $0 (2023) |
| UCB, Inc. | $134.12 | 8 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $132.36 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $239.84 | 12 | ABBVIE INC. ($144.33) |
| 2023 | $969.37 | 44 | ABBVIE INC. ($257.34) |
| 2022 | $1,454 | 71 | ABBVIE INC. ($470.94) |
| 2021 | $898.99 | 42 | AbbVie Inc. ($333.36) |
All Payment Transactions
169 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.60 | General |
| Category: IMMUNOLOGY | ||||||
| 05/30/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Dermatology | ||||||
| 05/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.64 | General |
| Category: IMMUNOLOGY | ||||||
| 05/08/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $21.83 | General |
| 04/03/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $23.97 | General |
| Category: Dermatology | ||||||
| 04/03/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $13.10 | General |
| Category: Dermatology | ||||||
| 04/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Immunology | ||||||
| 03/27/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: IMMUNOLOGY | ||||||
| 03/07/2024 | ABBVIE INC. | — | Education | In-kind items and services | $8.45 | General |
| 01/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.03 | General |
| Category: IMMUNOLOGY | ||||||
| 01/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: IMMUNOLOGY | ||||||
| 01/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: IMMUNOLOGY | ||||||
| 11/30/2023 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Immunology | ||||||
| 11/29/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $29.38 | General |
| Category: Immunology | ||||||
| 11/09/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.13 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/31/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $25.96 | General |
| Category: Dermatology | ||||||
| 10/25/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $21.99 | General |
| Category: DERMATOLOGY | ||||||
| 10/13/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.08 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $1.85 | General |
| Category: IMMUNOLOGY | ||||||
| 08/17/2023 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $14.96 | General |
| Category: Immunology | ||||||
| 08/04/2023 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $26.85 | General |
| Category: Dermatology | ||||||
| 08/02/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.46 | General |
| Category: IMMUNOLOGY | ||||||
| 07/13/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,614 | 2,969 | $524,130 | $109,626 |
| 2022 | 18 | 1,719 | 3,067 | $571,348 | $121,147 |
| 2021 | 20 | 1,645 | 2,805 | $533,479 | $132,582 |
| 2020 | 14 | 1,137 | 1,794 | $294,716 | $73,389 |
Total Patients
6,115
Total Services
10,635
Medicare Billing
$436,745
Procedure Codes
68
All Medicare Procedures & Services
68 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 403 | 532 | $130,872 | $29,864 | 22.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 204 | 266 | $96,292 | $21,420 | 22.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 159 | 188 | $65,048 | $12,450 | 19.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 225 | 308 | $70,532 | $11,881 | 16.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 123 | 145 | $56,985 | $10,812 | 19.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 163 | 1,101 | $27,525 | $5,497 | 20.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 106 | 123 | $18,450 | $5,030 | 27.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $17,430 | $4,360 | 25.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 37 | 37 | $10,175 | $2,248 | 22.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 38 | 38 | $9,652 | $1,684 | 17.5% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 12 | 14 | $4,900 | $1,383 | 28.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 30 | 33 | $6,138 | $1,197 | 19.5% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 11 | 11 | $4,125 | $843.30 | 20.4% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 12 | 14 | $2,730 | $506.81 | 18.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 39 | $2,730 | $385.56 | 14.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 27 | 78 | $546.00 | $63.30 | 11.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 377 | 521 | $128,166 | $29,662 | 23.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 225 | 301 | $108,962 | $23,676 | 21.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 174 | 199 | $68,854 | $13,230 | 19.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 225 | 302 | $69,158 | $11,191 | 16.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 118 | 137 | $53,841 | $10,486 | 19.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 84 | 84 | $23,100 | $5,744 | 24.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 54 | 54 | $22,410 | $5,456 | 24.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 169 | 1,007 | $25,175 | $4,930 | 19.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 99 | 121 | $18,150 | $4,473 | 24.6% |
About Naura Shah, PA-C
Naura Shah, PA-C is a Physician Assistant healthcare provider based in Norwood, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/11/2013. The National Provider Identifier (NPI) number assigned to this provider is 1417388711.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Naura Shah, PA-C has received a total of $3,562 in payments from pharmaceutical and medical device companies, with $239.84 received in 2024. These payments were reported across 169 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,297).
As a Medicare-enrolled provider, Shah has provided services to 6,115 Medicare beneficiaries, totaling 10,635 services with total Medicare billing of $436,745. Data is available for 4 years (2020–2023), covering 68 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Other Specialties Physician Assistant, Physician Assistant
- Location Norwood, MA
- Active Since 12/11/2013
- Last Updated 08/05/2021
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1417388711
Products in Payments
- SKYRIZI (Biological) $841.59
- DUPIXENT (Biological) $452.82
- OPZELURA (Drug) $371.10
- TREMFYA (Drug) $288.12
- RINVOQ (Biological) $197.45
- HUMIRA (Biological) $152.30
- TALTZ (Drug) $121.07
- Cimzia (Drug) $113.91
- EUCRISA (Drug) $102.60
- ADBRY (Biological) $96.93
- Sotyktu (Drug) $86.96
- ENSTILAR (Drug) $77.76
- COSENTYX (Drug) $71.32
- SPEVIGO (Drug) $62.92
- ILUMYA (Biological) $58.43
- AMZEEQ (Drug) $57.55
- COSENTYX (Biological) $39.21
- AKLIEF (Drug) $36.96
- EPSOLAY (Drug) $32.62
- REMICADE (Biological) $32.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Norwood
Virginia Oneil, Pa-C, PA-C
Physician Assistant — Payments: $3,052
Physician Assistant $3,052
Alicia Mckersie, Pac, PAC
Physician Assistant — Payments: $1,190
Physician Assistant $1,190
Ellen Wheeler, Pa-C, PA-C
Physician Assistant — Payments: $373.65
Physician Assistant $373.65
Lillian Kronz, Pa, PA
Physician Assistant — Payments: $259.50
Physician Assistant $259.50
Megan Montagne
Physician Assistant — Payments: $175.00
Physician Assistant $175.00
Andrew Brown, Pa, PA
Physician Assistant — Payments: $170.48
Physician Assistant $170.48